BCM
PFE icon

BBT Capital Management’s Pfizer PFE Stock Holding History

BBT Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,605
Closed -$436K – 107
2019
Q2 		$436K Buy
+10,605
New +$421K 0.51% 69
2014
Q1 		– Sell
-21,463
Closed -$624K – 322
2013
Q4 		$624K Hold
21,463
– – 0.03% 259
2013
Q3 		$585K Sell
21,463
-2,093,648
-99% -$57M 0.03% 266
2013
Q2 		$56.2M Buy
+2,115,111
New +$58.4M 2.97% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BBT Capital Management's PFE Position: Q3 2019 in Review

BBT Capital Management sold out of Pfizer (PFE) in Q3 2019, closing a stake of 10,605 shares — an estimated $436K sold.

BBT Capital Management first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $56.2M in Q2 2013. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • BBT Capital Management reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • BBT Capital Management sold 10,605 Pfizer shares in Q3 2019, an estimated $436K.
  • BBT Capital Management first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
  • BBT Capital Management's Pfizer position peaked at $56.2M in Q2 2013.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.